BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed TEVA catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:b0f487abde6314630780@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261113
DTEND;VALUE=DATE:20261114
SUMMARY:TEVA APPROVAL: IGALMI
DESCRIPTION:Approved 2026-11-13: IGALMI (NDA215390 SUPPL3)\nConfidence: con
 firmed\nTicker TEVA (confidence 0.6)\nSource: https://www.accessdata.fda.g
 ov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215390\nSchedu
 ling/reference data from public records\; dates can move. Not investment\,
  legal or medical advice.
TRANSP:TRANSPARENT
URL:https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overvie
 w.process&ApplNo=215390
CATEGORIES:approval,confirmed
END:VEVENT
BEGIN:VEVENT
UID:b13995ddb65bc4973214@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261008
DTEND;VALUE=DATE:20261009
SUMMARY:TEVA APPROVAL: WELTRUZA
DESCRIPTION:Approved 2026-10-08: WELTRUZA (NDA219007 ORIG1)\nConfidence: co
 nfirmed\nTicker TEVA (confidence 0.6)\nSource: https://www.accessdata.fda.
 gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219007\nSched
 uling/reference data from public records\; dates can move. Not investment\
 , legal or medical advice.
TRANSP:TRANSPARENT
URL:https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overvie
 w.process&ApplNo=219007
CATEGORIES:approval,confirmed
END:VEVENT
BEGIN:VEVENT
UID:490fa36f6bb6d140b93b@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20260925
DTEND;VALUE=DATE:20260926
SUMMARY:TEVA APPROVAL: DEGEVMA
DESCRIPTION:Approved 2026-09-25: DEGEVMA (BLA761481 ORIG1)\nConfidence: con
 firmed\nTicker TEVA (confidence 0.6)\nSource: https://www.accessdata.fda.g
 ov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761481\nSchedu
 ling/reference data from public records\; dates can move. Not investment\,
  legal or medical advice.
TRANSP:TRANSPARENT
URL:https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overvie
 w.process&ApplNo=761481
CATEGORIES:approval,confirmed
END:VEVENT
BEGIN:VEVENT
UID:5df4cc4007c9afbebd18@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20260327
DTEND;VALUE=DATE:20260328
SUMMARY:TEVA APPROVAL: PONLIMSI
DESCRIPTION:Approved 2026-03-27: PONLIMSI (BLA761385 ORIG1)\nConfidence: co
 nfirmed\nTicker TEVA (confidence 0.6)\nSource: https://www.accessdata.fda.
 gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761385\nSched
 uling/reference data from public records\; dates can move. Not investment\
 , legal or medical advice.
TRANSP:TRANSPARENT
URL:https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overvie
 w.process&ApplNo=761385
CATEGORIES:approval,confirmed
END:VEVENT
BEGIN:VEVENT
UID:dbaf5f10fbd11bf38131@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20251119
DTEND;VALUE=DATE:20251120
SUMMARY:TEVA APPROVAL: IGALMI
DESCRIPTION:Approved 2025-11-19: IGALMI (NDA215390 SUPPL2)\nConfidence: con
 firmed\nTicker TEVA (confidence 0.6)\nSource: https://www.accessdata.fda.g
 ov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215390\nSchedu
 ling/reference data from public records\; dates can move. Not investment\,
  legal or medical advice.
TRANSP:TRANSPARENT
URL:https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overvie
 w.process&ApplNo=215390
CATEGORIES:approval,confirmed
END:VEVENT
END:VCALENDAR
